Patient Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$13M |
| 2 |
United Airlines
UAL
|
+$6.08M |
| 3 |
Rocket Companies
RKT
|
+$3.67M |
| 4 |
OneMain Financial
OMF
|
+$2.88M |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$8.09M |
| 2 |
Herbalife
HLF
|
+$5.9M |
| 3 |
TUP
Tupperware Brands Corporation
TUP
|
+$5.84M |
| 4 |
Peloton Interactive
PTON
|
+$3.87M |
| 5 |
WW
WW International
WW
|
+$3.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 27.05% |
| 2 | Financials | 13.35% |
| 3 | Technology | 12.64% |
| 4 | Energy | 10.26% |
| 5 | Industrials | 8.51% |
Similar funds
Patient Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Patient Capital Management held 49 positions worth $226M, down 24% from $295M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Patient Capital Management deployed $8.23M of net new capital in Q2 2022, opening 4 new positions and adding to 25 existing holdings. Its largest new stake was Expedia Group: 92,075 shares worth $8.73M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Avid Technology Inc, an estimated $2.19M trimmed.
- Patient Capital Management's largest Q2 2022 buy was Expedia Group: 92,075 shares worth $8.73M.
- Patient Capital Management added most to Rocket Companies in Q2 2022, an estimated $3.67M increase.
- Patient Capital Management's biggest Q2 2022 reduction was Avid Technology Inc, cutting an estimated $2.19M.
- Patient Capital Management fully exited Tivity Health, Inc. Common Stock in Q2 2022, selling an estimated $8.09M.
- Patient Capital Management's ten largest holdings make up 46% of its $226M portfolio in Q2 2022.
- Patient Capital Management opened 4 new positions and closed 8 in Q2 2022.
- Patient Capital Management's portfolio value fell 24% quarter-over-quarter to $226M.
Based on Patient Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.